Jasper Therapeutics, Inc.

Develops mast cell-depleting antibody therapies for chronic diseases and stem cell transplants.

JSPR | US

Overview

Corporate Details

ISIN(s):: US4718712023 (+3 more)
LEI:
Country:: United States of America
Address:: 2200 BRIDGE PKWY SUITE #102, 94065 REDWOOD CITY
Website:: https://jaspertx.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing therapies for mast cell-driven diseases and as a conditioning agent for hematopoietic stem cell transplantation. The company's lead product candidate is briquilimab, a targeted anti-KIT (CD117) monoclonal antibody designed to deplete mast cells. Jasper is evaluating briquilimab in clinical studies for the treatment of chronic immunological and inflammatory diseases, including chronic spontaneous urticaria (CSU), chronic inducible urticaria (CIndU), and allergic asthma. The company's mission is to develop safer and more effective therapies for patients with serious chronic diseases by harnessing the power of mast cell depletion.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Jasper Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Jasper Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Jasper Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Japan Tissue Engineering Co., Ltd. Pioneers regenerative medicine with tissue products, CDMO services, and research models.	Japan	7774
Jazz Pharmaceuticals plc Develops medicines for serious diseases in neuroscience and oncology.	United States of America	JAZZ
JCR Pharmaceuticals Co.,Ltd. Develops therapies for rare genetic diseases, CNS disorders, and regenerative medicine.	Japan	4552
JEIL PHARMACEUTICAL CO.,LTD Global manufacturer of pharmaceutical APIs, antibiotics, and injection-based treatments.	South Korea	271980
JEIL PHARMA HOLDINGS INC. Develops and distributes APIs, generics, and modified drugs, specializing in injections.	South Korea	002620
JETEMA Co.,Ltd. Research-driven developer of aesthetic toxins, dermal fillers, and threads.	South Korea	216080
JIN YANG PHARMACEUTICAL. CO., LTD Develops and manufactures high-tech drugs for cancer, diabetes, and a range of diseases.	South Korea	007370
JOHNSON & JOHNSON Develops innovative medicines and medical technologies for complex diseases and personalized care.	United States of America	JNJ
Journey Medical Corp A pharmaceutical firm commercializing prescription drugs and generics for dermatology.	United States of America	DERM
JUPITER NEUROSCIENCES, INC. Pharma firm developing resveratrol treatments for neuroinflammation and rare diseases.	United States of America	JUNS